[STIGMATIZATION OF PATIENTS WITH SUBSTANCE USE DISORDERS AS A RISK FACTOR IN PSYCHO-NARCOLOGICAL CARE].

Q4 Medicine
T S Kugaevskaya
{"title":"[STIGMATIZATION OF PATIENTS WITH SUBSTANCE USE DISORDERS AS A RISK FACTOR IN PSYCHO-NARCOLOGICAL CARE].","authors":"T S Kugaevskaya","doi":"10.32687/0869-866X-2026-34-s1-448-452","DOIUrl":null,"url":null,"abstract":"<p><p>The relevance of the topic is determined by data from numerous studies indicating a significantly higher prevalence of stigma toward individuals using psychoactive substances compared to patients with other mental disorders. Stigma is recognized as a key problem in modern healthcare systems and is defined as a systemic factor shaping the entire ecosystem of narcological care. It frequently affects the professional activities of mid-level medical personnel manifesting at interconnected levels and forming a vicious cycle that deteriorates treatment quality and outcomes while undermining the health of the staff themselves. Stereotypical and negative perceptions of patients with addictions among mid-level medical personnel lead to discriminatory care practices: ignoring pain complaints unfounded suspicions and the use of derogatory language in communication and documentation. It is stigmatizing treatment that inflicts the most severe psychological trauma becoming the primary barrier to seeking help again. Intra-organizational stigma directly contributes to adverse clinical outcomes increased relapses and mortality. Combating stigma must become the cornerstone of professional support and training programs for mid-level medical personnel as well as efforts to improve the overall quality of narcological care.</p>","PeriodicalId":35946,"journal":{"name":"Problemy sotsial''noi gigieny i istoriia meditsiny / NII sotsial''noi gigieny, ekonomiki i upravleniia zdravookhraneniem im. N.A. Semashko RAMN, AO ''Assotsiatsiia ''Meditsinskaia literatura''","volume":"34 0","pages":"448-452"},"PeriodicalIF":0.0000,"publicationDate":"2026-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Problemy sotsial''noi gigieny i istoriia meditsiny / NII sotsial''noi gigieny, ekonomiki i upravleniia zdravookhraneniem im. N.A. Semashko RAMN, AO ''Assotsiatsiia ''Meditsinskaia literatura''","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32687/0869-866X-2026-34-s1-448-452","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The relevance of the topic is determined by data from numerous studies indicating a significantly higher prevalence of stigma toward individuals using psychoactive substances compared to patients with other mental disorders. Stigma is recognized as a key problem in modern healthcare systems and is defined as a systemic factor shaping the entire ecosystem of narcological care. It frequently affects the professional activities of mid-level medical personnel manifesting at interconnected levels and forming a vicious cycle that deteriorates treatment quality and outcomes while undermining the health of the staff themselves. Stereotypical and negative perceptions of patients with addictions among mid-level medical personnel lead to discriminatory care practices: ignoring pain complaints unfounded suspicions and the use of derogatory language in communication and documentation. It is stigmatizing treatment that inflicts the most severe psychological trauma becoming the primary barrier to seeking help again. Intra-organizational stigma directly contributes to adverse clinical outcomes increased relapses and mortality. Combating stigma must become the cornerstone of professional support and training programs for mid-level medical personnel as well as efforts to improve the overall quality of narcological care.

[将药物使用障碍患者污名化,认为这是精神病治疗中的一个危险因素]。
许多研究的数据表明,与患有其他精神障碍的患者相比,使用精神活性物质的个体的耻辱感明显更高,从而确定了该主题的相关性。病耻感被认为是现代卫生保健系统中的一个关键问题,并被定义为塑造整个麻醉科护理生态系统的系统因素。它经常影响中级医务人员的专业活动,在相互关联的层面上表现出来,形成恶性循环,使治疗质量和结果恶化,同时损害工作人员本身的健康。中级医务人员对成瘾患者的刻板印象和负面看法导致歧视性护理做法:忽视疼痛投诉,毫无根据的怀疑,并在沟通和文件中使用贬损的语言。污名化的治疗造成了最严重的心理创伤,成为再次寻求帮助的主要障碍。组织内的病耻感直接导致不良的临床结果,增加了复发率和死亡率。消除耻辱感必须成为对中级医疗人员的专业支持和培训计划的基石,同时也必须努力提高麻醉科护理的整体质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.40
自引率
0.00%
发文量
234
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书